This page includes Regulatory news filings supplied by issuers listed on the BSX. Please note the BSX is not responsible for the content, accuracy or completeness of announcements filed by issuers and disclaims all liability for any loss arising from reliance on information contained within issuer announcements.
HSBC Holdings plc Announces Board Appointments
Hamilton, Bermuda: 28th January 2005 - John Coombe (59) and James Hughes-Hallett (55) have been appointed Directors of HSBC Holdings plc with effect from 1 March 2005.
Mr Coombe, an independent non-executive Director, has also been appointed to the Group Audit Committee of HSBC Holdings plc with effect from 1 July 2005. He is Chief Financial Officer of GlaxoSmithKline plc, a position he has held since December 2000 following Glaxo Holdings' merger with SmithKline Beecham.Mr Coombe joined Glaxo Holdings as Group Financial Controller in 1986.
Mr Hughes-Hallett, an independent non-executive Director, is Chairman of John Swire & Sons Limited. He joined the Swire Group in 1976 and, before taking up his current role, was based in Hong Kong as Chairman of Swire Pacific Ltd, Cathay Pacific Airways Ltd and John Swire & Sons (HK) Ltd.
Media enquiries to Karen Ng on +44 (0)20 7991 0655.
Note to editors:
The HSBC Group
HSBC Holdings plc is headquartered in the UK. The HSBC Group serves over 110 million customers worldwide from approximately 10,000 offices in 76 countries and territories in Europe, the Asia-Pacific region, the Americas, the Middle East and Africa. With assets of US$1,154 billion at 30 June 2004, HSBC is one of the world's largest banking and financial services organisations. HSBC is marketed worldwide as €˜the world's local bank'.